Insulin Delivery Devices Market: High cost of devices to result in slow and low adoption rates

The Increasing market demand regarding minimally invasive alternatives and insulin-delivering devices such as advancements in insulin devices and pumps in terms of proper functioning, design and rising prevention of diabetes and the comfort offered by some insulin delivery instruments and devices to patients are a some of the main market expansion driving factors determined globally. The increasing worldwide prevalence of diabetes is the main reason behind insulin delivery devices market growth. As a result of inappropriate eating habits and lack of physical work; diabetes incidences are increasing at an alarming rate in developing countries too. From the consumer’s aspect, usage complication and the likelihood of injury due to the shift from invasive devices to minimally presumptuous ones.

Market Drivers and Restraints:

The insulin delivery devices market faces some unique challenges that have been and will continue to be preventing growth throughout the forecast period. Factors such as the high price of insulin and insulin delivery devices, inconsistencies in adherence to insulin uptake and psychological resistances to self-injection because of the needle-phobia are the main roadblock in insulin delivery devices market expansion. Low per capita of diabetes expenditure and short of compensation and insurance coverage in rising economies happen to be significant constraints in business growth. Throughout the forecast period, the high price of devices will result in slow and low adoption rates, mainly in weak resource economies.

To know more, click on the link below:

Report segmented as:

By Types:

·        Insulin Syringes

·        Insulin Pens

·        Insulin Pen Needles

·        Insulin Pumps

·        Insulin Jet Injectors

By Application:

·        Type I Diabetes

·        Type II Diabetes

Geographical Analysis:

Earlier the U.S. insulin delivery devices market was worth USD 5.0 billion in 2018 that to the putative regional share of around 95% in 2018. Increasing diabetes prevention coupled with escalating disposable income level will drive market growth over the forecast period. The Germany insulin delivery devices market was around 30% of the original regional revenue share in 2018. Whereas, the China insulin delivery device market was worth USD 1.1 billion in 2018 and it is estimated to witness around 14% growth over the forecast period. With its immense diabetic population and quick economic development, the country spends almost USD 25 billion for treating diabetes-related diseases annually. Nevertheless, only about 35% of the diabetic population is aware of being diabetic and are receiving treatment for their condition, whereas rest are unidentified. Betterment in diagnosis rate and increased awareness towards early diagnosis will drive demand for insulin delivery devices over the forecast period.

Important Market Players:

Insulin Delivery Devices Market consists of some important key market players. They are Abbott Laboratories, Becton, Dickinson and Company, F. Hoffman-La Roche, Ltd., Eli Lily and Company, Sanofi, Medtronic, Inc., Novo Nordisk A/S,YpsomedHolding AG, and many more.

View a sample and decide @

The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast


Tel: +1-888-702-9626